Analysts Viewpoint
Analysts: ELVN stock price target of 45.5 in 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Enliven Therapeutics
Enliven Therapeutics Inc’s recent filing unveils that its CHIEF OPERATING OFFICER Patel Anish unloaded Company’s shares for reported $0.12 million
In a filing, Enliven Therapeutics Inc revealed its CHIEF FINANCIAL OFFICER Hohl Benjamin unloaded Company’s shares for reported $66504.0 on
In a filing, Enliven Therapeutics Inc revealed its Officer Hohl Benjamin acquired Company’s shares for reported $90100.0 on Jul 28